Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00304_DB00307> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00304_DB00307 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00304_DB00307 label "DDI between Desogestrel and Bexarotene - Bexarotene may decrease the serum concentration of Contraceptives (Progestins). Since bexarotene is teratogenic and can lower serum concentrations of desogestrel, it is advised that women of childbearing potential use two forms of contraception (including at least one non-hormonal form). [drugbank_resource:DB00304_DB00307]" assertion.
- drugbank_resource:DB00304_DB00307 identifier "drugbank_resource:DB00304_DB00307" assertion.
- drugbank_resource:DB00304_DB00307 title "DDI between Desogestrel and Bexarotene - Bexarotene may decrease the serum concentration of Contraceptives (Progestins). Since bexarotene is teratogenic and can lower serum concentrations of desogestrel, it is advised that women of childbearing potential use two forms of contraception (including at least one non-hormonal form)." assertion.